Product Program year 2025 Source: CMS Open Payments

Zusduri

Drug Lg-Ir-Nmibc

NDC 72493-106-03

Open in the dashboard

General payments

$581,679

2,931 payments

Research payments

$0

0 payments

Through program year 2025, $581,679 in general payments and $0 in research payments were reported against Zusduri (Lg-Ir-Nmibc).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $581,679 2,931

Breakdown

Who paid General payments · program year 2025
  1. Urogen Pharma, Inc. $581,679 2,931 payments
Top recipients General payments · program year 2025
  1. Katie Murray Urology · New York, NY $68,678 12% · 47 payments
  2. Sandip Prasad Urology · Charleston, SC $54,789 9% · 48 payments
  3. John Sfakianos Urology · New York, NY $53,368 9% · 32 payments
  4. Brian Hu Urology · Loma Linda, CA $44,364 8% · 35 payments
  5. Meredith Metcalf Urology · Saint Louis, MO $22,575 4% · 18 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $516,529 94% · 1,228 practitioners
  2. Physician Assistant $7,375 1% · 157 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $7,153 1% · 157 practitioners
  4. Nurse Practitioner $3,996 <1% · 77 practitioners
  5. Medical Oncology Internal Medicine $1,855 <1% · 4 practitioners

The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $143,599 25% · 67 recipients
  2. California $95,005 16% · 239 recipients
  3. South Carolina $58,127 10% · 32 recipients
  4. Missouri $32,564 6% · 59 recipients
  5. Tennessee $30,706 5% · 109 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,931 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record